In addition, an MYC-dependent metabolic switch from glutaminase 2 (GLS2) to GLS1 may occur during HCC progression, enabling metabolic rewiring by increasing glutamine uptake and decomposition rate in tumor cells [11]. This evidence concerns the gene GLS2 and neoplasm.